Stem Cells International / 2015 / Article / Tab 1

Research Article

Multiple Myeloma Patients at Various Cytogenetic Risks Benefit Differently from Autologous Stem Cell Transplantation as a Consolidation Therapy

Table 1

Characteristic comparison of MM patients with or without ASCT in three risk subgroups.

High risk Intermediate risk Low risk
Non-ASCTASCTNon-ASCTASCTNon-ASCTASCT

Number171724242626
Average age (years)56.0 52.0 0.15454.0 51.40.28853.553.0 0.820
Male/female11/69/80.48616/816/81.000 18/814/120.254
IgA class29.40%23.50%1.000 25.00%20.80%0.73119.20%19.20%1.000
Average hemoglobin (g/L)85.572.40.16976.977.70.948 110.495.70.136
Average serum calcium (mmol/L)2.692.380.1432.622.80 0.3562.442.420.899
Average creatinine (umol/L)136.8188.30.456224.3160.0 0.49374.0 90.80.189
Average albumin (g/L)32.531.40.72834.738.90.13336.536.0 0.891
Average 2 microglobulin (mg/L)6.026.250.8848.276.540.3743.043.540.33
Median bone marrow plasma cells49.2%46.2%0.8037.6%13.8%0.44128.8%35.3%0.382
nCR/CR rate41.20%47.10%0.730 29.20%37.50%0.540 42.30%50.00%0.578